We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




LIMS Upgrade Has Over 100 Enhancements

By LabMedica International staff writers
Posted on 17 Nov 2009
Print article
A fully integrated laboratory information-management system (LIMS) is ideally suited to manage an organization's product development, quality management, and analytic laboratories.

Lab Vantage Solutions, Inc. (Bridgewater, NJ, USA) announced the release of Service Pack 7 (SP7) for the SQL*LIMS product platform. The SP7 release includes over 100 enhancements, and it offers new additional capabilities including: enhanced graphical user interface; extended dashboard data table and worklist; advanced calculation verification capabilities; native crystal reports support; and Microsoft Windows Vista support.

"The release of SP7 highlights our commitment to continued support for our SQL*LIMS customers," stated Pat Pijanowski, chief operating officer of LabVantage. "With our expanded product portfolio and over 250 direct employees around the world, the new LabVantage is uniquely positioned to support our customers and their global operations well into the future.”

LabVantage is a global provider of enterprise software solutions customized for laboratories serving research, development, analytic, and quality management laboratories across multiple industries.

Related Links:
Lab Vantage Solutions




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.